1
|
Perdigão MMDM, Rodrigues AB, Carvalho REFLD, Oliveira SKPD, Anjos SDJSBD, Almeida PCD. Distress em Pacientes Oncológicos no Brasil: Revisão Integrativa da Literatura. REVISTA BRASILEIRA DE CANCEROLOGIA 2022. [DOI: 10.32635/2176-9745.rbc.2022v68n3.2402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022] Open
Abstract
Introdução: O paciente oncológico vivencia uma serie de mudanças em sua vida diante do diagnóstico e do tratamento, sendo o aspecto emocional um dos atingidos nesse processo. O termo “distress” foi escolhido para se referir ao sofrimento emocional vivenciado pelo paciente oncológico. Objetivo: Identificar como o distress em pacientes oncológicos tem sido abordado em estudos realizados no Brasil. Método: Revisão integrativa da literatura cientifica sobre o distress realizada em setembro de 2020. Para a busca nas bases de dados, utilizaram-se o descritor “Neoplasias” e o termo “Distress”. Foram selecionados artigos disponíveis na integra publicados em português, inglês ou espanhol, tendo como assunto pais/Região: Brasil, sem corte temporal, nas bases de dados LILACS, MEDLINE e BDENF. Foi realizada a etapa de leitura crítica para análise e síntese dos artigos. Os artigos selecionados foram organizados e apresentados na forma de quadro e a interpretação dos resultados em categorias. Resultados: A amostra final desta revisão resultou em nove artigos que apontaram instrumentos capazes de identificar e/ou medir o distress, discorreram sobre os fatores associados a presença do distress e os fatores que impactaram na redução dos distress. Conclusão: O paciente com câncer pode vivenciar o distress em qualquer fase da doença. Diante da escassez de artigos acerca do distress no cenário brasileiro, recomenda-se que se desenvolvam mais estudos a fim de aprofundar e consubstanciar a temática.
Collapse
|
2
|
Bergerot CD, Razavi M, Philip EJ, Bergerot PG, Buso MM, Clark KL, Loscalzo M, Pal SK, Dale W. Association between hospital anxiety and depression scale and problem-related distress in patients with cancer in a Brazilian private institution. Psychooncology 2020; 30:296-302. [PMID: 33044794 DOI: 10.1002/pon.5571] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2020] [Revised: 08/23/2020] [Accepted: 10/07/2020] [Indexed: 11/09/2022]
Abstract
OBJECTIVE Emotional symptoms are frequently reported among patients with cancer. We evaluated the association between emotional symptoms and problem-related distress in a sample of patients with cancer about to initiate chemotherapy within a private hospital in Brazil. METHODS Patients were assessed before initiating chemotherapy, treatment mid-point, and on the last day of treatment for anxiety and depression (Hospital Anxiety and Depression Scale [HADS]) and for problem-related distress (Distress Thermometer Problem List). Problem-related distress variable was computed as the sum of practical, physical, spiritual and familial problems. Mixed-model analysis was applied to determine the association between HADS and problem-related distress, adjusting for age and gender. RESULTS A total of 655 consecutive patients were enrolled. There was a significant main effect of time (F = 8.99, p = 0.0001), showing that emotional symptoms improve over time. A significant main effect was observed for problem-related distress (F = 371.56, p < 0.0001) revealing that patients with elevated problem-related distress at baseline tend to have higher HADS across the three time points, compared to patients with lower problem-related distress. There was an interaction effect between problem-related distress and time (F = 85.22, p < 0.0001), suggesting that HADS scores decreased differently over time, depending on patients' initial level of problem-related distress. CONCLUSION Overall, emotional symptoms, while decreasing over time, remained associated with problem-related distress after chemotherapy in Brazil. The potential benefit of implementing a psychosocial intervention remains high throughout cancer treatment.
Collapse
Affiliation(s)
- Cristiane D Bergerot
- Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California, USA.,Instituto Unity de Ensino e Pesquisa, Centro de Câncer de Brasília (CETTRO), Brasília, DF, Brazil
| | - Marianne Razavi
- Department of Supportive Care Medicine, City of Hope-National Medical Center, Duarte, California, USA
| | - Errol J Philip
- Medical School, University of California San Francisco, San Francisco, California, USA
| | - Paulo G Bergerot
- Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California, USA.,Instituto Unity de Ensino e Pesquisa, Centro de Câncer de Brasília (CETTRO), Brasília, DF, Brazil
| | - Marco M Buso
- Department of Oncology, Centro de Câncer de Brasília (CETTRO), Brasília, DF, Brazil
| | - Karen L Clark
- Department of Supportive Care Medicine, City of Hope-National Medical Center, Duarte, California, USA
| | - Matthew Loscalzo
- Department of Supportive Care Medicine, City of Hope-National Medical Center, Duarte, California, USA
| | - Sumanta K Pal
- Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California, USA
| | - William Dale
- Department of Supportive Care Medicine, City of Hope-National Medical Center, Duarte, California, USA
| |
Collapse
|